Literature DB >> 9029239

Evidence that nitric oxide increases glucose transport in skeletal muscle.

T W Balon1, J L Nadler.   

Abstract

Nitric oxide synthase (NOS) is expressed in skeletal muscle. However, the role of nitric oxide (NO) in glucose transport in this tissue remains unclear. To determine the role of NO in modulating glucose transport, 2-deoxyglucose (2-DG) transport was measured in rat extensor digitorum longus (EDL) muscles that were exposed to either a maximally stimulating concentration of insulin or to an electrical stimulation protocol, in the presence of NG-monomethyl-L-arginine, a NOS inhibitor. In addition, EDL preparations were exposed to sodium nitroprusside (SNP), an NO donor, in the presence of submaximal and maximally stimulating concentrations of insulin. NOS inhibition reduced both basal and exercise-enhanced 2-DG transport but had no effect on insulin-stimulated 2-DG transport. Furthermore, SNP increased 2-DG transport in a dose-responsive manner. The effects of SNP and insulin on 2-DG transport were additive when insulin was present in physiological but not in pharmacological concentrations. Chronic treadmill training increased protein expression of both type I and type III NOS in soleus muscle homogenates. Our results suggest that NO may be a potential mediator of exercise-induced glucose transport.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9029239     DOI: 10.1152/jappl.1997.82.1.359

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  80 in total

Review 1.  Respiratory muscle function and free radicals: from cell to COPD.

Authors:  L M Heunks; P N Dekhuijzen
Journal:  Thorax       Date:  2000-08       Impact factor: 9.139

Review 2.  Cellular and molecular regulation of cardiac glucose transport.

Authors:  L H Young; D L Coven; R R Russell
Journal:  J Nucl Cardiol       Date:  2000 May-Jun       Impact factor: 5.952

Review 3.  Role of nitric oxide in the regulation of substrate metabolism in heart failure.

Authors:  Fabio A Recchia
Journal:  Heart Fail Rev       Date:  2002-04       Impact factor: 4.214

Review 4.  The exercise-induced growth hormone response in athletes.

Authors:  Richard J Godfrey; Zahra Madgwick; Gregory P Whyte
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

5.  T-1032, a cyclic GMP phosphodiesterase-5 inhibitor, acutely blocks physiologic insulin-mediated muscle haemodynamic effects and glucose uptake in vivo.

Authors:  Hema Mahajan; Stephen M Richards; Stephen Rattigan; Michael G Clark
Journal:  Br J Pharmacol       Date:  2003-10-27       Impact factor: 8.739

6.  Dipyridamole reverses peripheral ischemia and induces angiogenesis in the Db/Db diabetic mouse hind-limb model by decreasing oxidative stress.

Authors:  Christopher B Pattillo; Shyamal C Bir; Billy G Branch; Eric Greber; Xinggui Shen; Sibile Pardue; Rakesh P Patel; Christopher G Kevil
Journal:  Free Radic Biol Med       Date:  2010-11-09       Impact factor: 7.376

7.  Fine-tuning insulin and nitric oxide signalling by turning up the AMPs: new insights into AMP-activated protein kinase signalling.

Authors:  Y C Long; J R Zierath
Journal:  Diabetologia       Date:  2005-11-11       Impact factor: 10.122

8.  Many pathways are called! Many may be chosen!

Authors:  Thomas W Balon
Journal:  J Physiol       Date:  2006-06-29       Impact factor: 5.182

Review 9.  nNOS regulation of skeletal muscle fatigue and exercise performance.

Authors:  Justin M Percival
Journal:  Biophys Rev       Date:  2011-11-08

Review 10.  Signaling mechanisms in skeletal muscle: acute responses and chronic adaptations to exercise.

Authors:  Katja S C Röckl; Carol A Witczak; Laurie J Goodyear
Journal:  IUBMB Life       Date:  2008-03       Impact factor: 3.885

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.